Development of Bioprocesses for the Generation of Anti-Inflammatory, Anti-Viral and Anti-Leukaemic Agents

  • Mahmoudian M
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A review with several refs. This chapter is based on a lecture presented at the 9th European Congress on Biotechnol. held in Belgium, Brussels (11-15th July 1999) and gives an overview of several bioprocesses that have recently been developed at Glaxo Wellcome. Three bioprocesses, to produce key chiral intermediates for the synthesis of drug candidates, are described. (1) The nucleoside oxidase from Stenotrophomonas maltophilia was used to generate 5'-carboxylic acid derivs. of nucleoside analogs as key intermediates in the synthesis of a novel group of compds. with broad anti-inflammatory properties. The synthetic utility of the enzyme was exploited to produce 5'-carboxylates of several purine nucleoside analogs, including the carbocyclic nucleosides aristeromycin and neplanocin A on a preparative scale. The enzyme was found to have surprisingly wide substrate specificity toward unnatural nucleosides esp. in the base moiety. (2)A serine-type protease from an alkalophilic Bacillus sp. was used to resolve racemic N-substituted lactams as key intermediates in the synthesis of abacavir (Ziagen), a selective and potent reverse transcriptase inhibitor which was recently approved by the FDA for the treatment of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections in adults and children. A simple and efficient process, using com. available hydrolytic enzymes, was developed to produce enantiomerically pure N-substituted gamma -lactams. (3) A co-immobilized uridine phosphorylase and purine nucleoside phosphorylase prepn. from recombinant E. coli strains was used in the prodn. of the anti-leukemic agent 506U78. Fermn. and bioconversion conditions were optimized and scaled up with up to 200 g/L of substrate input and the co-immobilized enzymes could be re-used several times in bioreactors. In a parallel process an immobilized prepn. of Candida antarctica lipase was used to produce esters of 506U78 which were shown to have a better water soly. and bioavailability. Vinyl. Acetate was used as an acyl donor and reactions were carried out in anhyd. 1,4-dioxane with up to 100 g/L of substrate input. [on SciFinder (R)]

Cite

CITATION STYLE

APA

Mahmoudian, M. (2001). Development of Bioprocesses for the Generation of Anti-Inflammatory, Anti-Viral and Anti-Leukaemic Agents (pp. 249–265). https://doi.org/10.1007/0-306-46885-9_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free